This report identifies the global hormone replacement therapy market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global hormone replacement therapy market.
Geographically North America dominated global hormone replacement therapy market, and Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, growing awareness on symptoms and availability of therapies, and modernizing healthcare infrastructure in developing nations such as China, and India in this region. Among all the products, estrogen replacement therapy has the highest market share in global hormone replacement therapy market.
This report segments global hormone replacement therapy market on the basis of product, route, disease, and regional market as follows:
Hormone Replacement Therapy Market, By Product: Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, and Others
Hormone Replacement Therapy Market, By Route: Oral, Parenteral, Transdermal, and Others
The report has focused study on hormone replacement therapy market by basis of disease such as: Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the hormone replacement therapy market. Some of the major companies’ profiles in detail are as follows:
Abbott Point of Care, Inc.
Merck & Co. Inc.
Bayer Pharma AG
Hisamitsu Pharmaceutical Co., Inc.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Hormone Replacement Therapy Market– Market Forces
4.1.1. Development of highly innovative drug delivery systems
4.1.2. Rise in the number of menopausal women
4.1.3. Increasing awareness on post-menopausal hazards
4.2.1. Higher cost of therapy
4.2.2. Risk of cancer and blood clotting
4.3.1. Emerging economies
4.3.2. Increase in adoption of anti-aging therapy and newer formulations
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Hormone Replacement Therapy Market, By Product
5.1. Estrogen Replacement Therapy
5.2. Human Growth Hormone Replacement Therapy
5.3. Thyroid Replacement Therapy
6. Hormone Replacement Therapy Market, By Route
7. Hormone Replacement Therapy Market, By Disease
7.3. Male Hypogonadism
7.4. Growth Hormone Deficiency
8. Hormone Replacement Therapy Market, By Geography
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.4. Rest of the World (RoW)
8.4.2. Rest of RoW
9. Hormone Replacement Therapy – Market Entropy
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
10.1. Abbott Point of Care, Inc.
10.2. Merck &Co. Inc.
10.3. Bayer Pharma AG
10.4. QuatRx Pharmaeuticals
10.5. Hisamitsu Pharmaceutical Co., Inc.
10.6. Actavis Plc.
10.7. Novo Nordisk
10.8. Mylan Laboratories
10.9. Novartis AG
10.10. Pfizer Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.4. Expert Insights